Answers are grounded in this paper and cite their sources.
Shows IBP35 improves immune responses in immunosuppressed mice, suggesting potential therapeutic benefits.
< 0.001). Histological analysis revealed that IBP35 attenuated CPA-induced splenic atrophy and lymphoid depletion. In healthy mice, IBP35 modulated immune responses without inducing excessive inflammation. Collectively, these results indicate that IBP35 modulates both innate and adaptive immune readouts and supports immune function under immunosuppressed conditions.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: